台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    65.0
  • 漲跌
    ▼2.3
  • 漲幅
    -3.42%
  • 成交量
    434
  • 產業
    上櫃 生技醫療類股
  • 73人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
易威 (1799)籌碼相關-華南永昌-高雄 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

華南永昌-高雄 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/2900.00359.5062.50-3464-0.65%
2025/04/223.156.2100.0055.503.14710.66%
2025/04/1800.00359.3059.30-3482-0.62%
2025/04/1700.00058.8058.6004890.00%
2025/04/160.158.80062.0059.000.14900.02%
2025/04/14358.6000.0059.4034920.61%
2025/04/11061.00359.5059.20-3493-0.61%
2025/04/1000.00156.1056.30-1488-0.20%
2025/04/09453.2000.0051.2044910.81%
2025/04/0800.00156.0055.40-1486-0.21%
2025/03/2500.00174.8076.00-1594-0.17%
2025/03/19273.3000.0072.6025980.33%
2025/03/1800.00975.8475.50-9602-1.49%
2025/03/17278.101078.4077.50-8616-1.30%
2025/03/14477.83979.3477.70-5617-0.81%
2025/03/131780.183378.6281.00-16603-2.65%
2025/03/12578.141278.8577.50-7585-1.20%
2025/03/1141.581.723777.3881.504.55570.81%
2025/03/103773.501.276.8076.8035.85186.91%
2025/02/2600.00166.5066.40-1490-0.20%
2025/02/1700.00163.7062.20-1521-0.19%
2025/02/14161.80163.0063.0005430.00%
2025/02/12162.5000.0061.9015850.17%
2024/12/3100.001264.3164.30-12669-1.79%
2024/12/301267.45166.4066.70116921.59%
2024/12/27163.804963.4563.30-48697-6.89%
2024/12/263469.632169.8466.60136921.88%
2024/12/254174.56175.5074.00406835.86%
2024/12/24072.0000.0073.0006770.00%
2024/12/19065.0000.0062.7006950.00%
2024/12/1800.00358.5060.90-3678-0.44%
2024/12/17055.3000.0055.4006780.00%
2024/12/06464.5800.0064.3046510.61%
2024/11/22170.7000.0073.0016720.15%
2024/11/15171.5000.0066.0016780.15%
2024/11/1400.00266.8069.00-2670-0.30%
2024/11/13263.9000.0064.0026520.31%
2024/11/1200.00263.5070.00-2632-0.32%
2024/10/0800.000.1128.00126.00-0.1839-0.01%
2024/10/0700.005116.50116.50-5830-0.60%
2024/09/305108.0000.00108.0057770.64%
2024/09/271120.001124.00120.0007960.00%
2024/09/231158.0000.00158.0017940.13%
2024/08/2900.000.4220.00221.00-0.4795-0.05%
2024/08/0900.001184.50203.50-1824-0.12%
2024/08/071174.0000.00180.0017810.13%
2024/08/0600.001173.00171.00-1777-0.13%
2024/07/301144.002140.50148.00-1716-0.14%
2024/07/291150.001150.00141.5007080.00%
2024/07/2300.001160.00160.00-1685-0.15%
2024/07/221165.0000.00164.0016670.15%
2024/07/1900.002177.00182.00-2650-0.31%
2024/07/1000.000152.50152.5005120.00%
2024/07/031125.001133.00124.5004740.00%
2024/07/011137.0000.00137.5014350.23%
2024/06/281123.000125.50130.0014130.24%
2024/06/2700.000118.50118.5003930.00%
2024/06/171105.5000.00108.0013530.28%
2024/06/1400.00198.4098.60-1329-0.30%
2024/05/2300.00094.90100.5002860.00%
2024/05/2100.00188.0993.00-1250-0.40%
2024/05/20182.0000.0086.3012380.42%
2024/05/1600.00075.9075.000226-0.01%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音